Point72 Asset Management
VYGR icon

Point72 Asset Management’s Voyager Therapeutics VYGR Stock Holding History

Point72 Asset Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
268,223
+172,872
+181% +$681K ﹤0.01% 2743
2025
Q4 		$375K Buy
+95,351
New +$422K ﹤0.01% 3380
2025
Q1 		– Sell
-1,182
Closed -$6.7K – 2584
2024
Q4 		$6.7K Buy
+1,182
New +$7.62K ﹤0.01% 2032
2023
Q2 		– Sell
-6,224
Closed -$48K – 2832
2023
Q1 		$48K Buy
+6,224
New +$49.5K ﹤0.01% 1792
2022
Q4 		– Sell
-289,420
Closed -$1.71M – 1814
2022
Q3 		$1.71M Buy
+289,420
New +$1.85M 0.01% 952
2018
Q4 		– Sell
-101,975
Closed -$1.93M – 1227
2018
Q3 		$1.93M Buy
+101,975
New +$1.96M 0.01% 768
2017
Q4 		– Sell
-130,900
Closed -$2.69M – 1095
2017
Q3 		$2.69M Buy
+130,900
New +$1.48M 0.01% 637

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management's VYGR Position: Q1 2026 in Review

Point72 Asset Management increased its Voyager Therapeutics (VYGR) stake by 181% in Q1 2026, buying an estimated $681K and bringing the position to 268,223 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Point72 Asset Management first reported a position in VYGR in Q3 2017 and has held it in 7 quarters since. The position peaked at $2.69M in Q3 2017. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Point72 Asset Management held 268,223 shares of Voyager Therapeutics worth $1.04M as of Q1 2026.
  • Point72 Asset Management bought 172,872 Voyager Therapeutics shares in Q1 2026, an estimated $681K.
  • Voyager Therapeutics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2743 holding.
  • Point72 Asset Management first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 7 quarters since.
  • Point72 Asset Management's Voyager Therapeutics position peaked at $2.69M in Q3 2017.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.